Ferriprotoporphyrin IX (Hemozoin formation) (FP-IX)

Ferriprotoporphyrin IX (FP-IX), commonly referred to as heme, is a highly toxic byproduct generated during the intraerythrocytic stage of the Plasmodium parasite's life cycle. As the parasite digests host hemoglobin within its acidic food vacuole to acquire essential amino acids, it releases large quantities of FP-IX, which can cause oxidative stress and membrane lysis (PubMed: 11591733). To survive, the parasite detoxifies this molecule by sequestering it into an insoluble, chemically inert crystalline polymer known as hemozoin, or malaria pigment (NCBI: NBK22445). This biocrystallization process is unique to the parasite and essential for its viability, making it a premier target for antimalarial chemotherapy. Quinolines and related drugs, such as chloroquine and quinine, exert their therapeutic effect by interfering with this crystallization process, thereby allowing toxic heme to accumulate and kill the parasite (StatPearls: NBK551512). Despite its historical success as a target, the emergence of resistance mechanisms, such as the PfCRT transporter which pumps drugs out of the food vacuole, remains a significant challenge in global malaria control (Wikipedia: Hemozoin).

Other names

HemeHematinMalaria pigmentBeta-hematinHemozoin biocrystallizationHeme detoxification pathway

Inhibition of hemozoin formation (biocrystallization) by binding to ferriprotoporphyrin IX or the growing crystal face, leading to the accumulation of toxic free heme which causes parasite membrane damage and death.